Long Focus Capital Management, LLC

Holdings History for ADAPTIMMUNE THERAPEUTICS PLC - American Depositary Shares, each representing 6 Ordinary Shares (ADAPY)

Symbol: ADAPY
Investment type: Equity / American Depositary Shares, each representing 6 Ordinary Shares
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

LONG FOCUS CAPITAL MANAGEMENT, LLC ownership in ADAPTIMMUNE THERAPEUTICS PLC American Depositary Shares, each representing 6 Ordinary Shares (ADAPY)

17 Feb 2026 - LONG FOCUS CAPITAL MANAGEMENT, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of ADAPTIMMUNE THERAPEUTICS PLC American Depositary Shares, each representing 6 Ordinary Shares (ADAPY). This represents 0% ownership of the company. In their previous filing dated 11 Feb 2025, Long Focus Capital Management, LLC had reported owning 20,494,393 shares, indicating a decrease of +100%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
LONG FOCUS CAPITAL MANAGEMENT, LLC	0%	-100%	$0	0	-20,494,393	-100%	$0.03	13G	31 Dec 2025	17 Feb 2026, 08:54
LONG FOCUS CAPITAL MANAGEMENT, LLC	8%		$5,533,486	20,494,393			$0.27	13G/A	31 Dec 2024	11 Feb 2025, 16:40

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-0.14%	$0	0	-18,577,821	-100%	$0.03	Q4 2025
30 Sep 2025	0.14%	-0.04%	$2,415,117	18,577,821	-5,178,866	-22%	$0.13	Q3 2025
30 Jun 2025	0.37%	0%	$5,694,478	23,756,687	0		$0.24	Q2 2025
31 Mar 2025	0.32%	+0.04%	$4,680,067	23,756,687	+3,262,294		$0.20	Q1 2025
31 Dec 2024	0.85%	+0.3%	$11,040,330	20,494,393	+7,194,503	+54%	$0.54	Q4 2024
30 Sep 2024	1.1%	+0.08%	$12,640,215	13,299,890	+953,473	+7.7%	$0.95	Q3 2024
30 Jun 2024	1.2%	+0.19%	$12,036,522	12,346,417	+1,662,184	+16%	$0.97	Q2 2024
31 Mar 2024	1.9%	-0.26%	$16,881,088	10,684,233	-1,402,682	-12%	$1.58	Q1 2024
31 Dec 2023	1.2%	+0.12%	$9,584,924	12,086,915	+1,123,757	+10%	$0.79	Q4 2023
30 Sep 2023	1.2%	+0.35%	$8,551,263	10,963,158	+3,150,630	+40%	$0.78	Q3 2023
30 Jun 2023	1.1%	+0.33%	$7,226,588	7,812,528	+2,377,089	+44%	$0.92	Q2 2023
31 Mar 2023	0.96%	+0.03%	$5,924,629	5,435,439	+151,800	+2.9%	$1.09	Q1 2023
31 Dec 2022	1.3%	+0.12%	$7,714,113	5,283,639	+494,149	+10%	$1.46	Q4 2022
30 Sep 2022	1.1%	+0.02%	$5,149,000	4,789,490	+109,999	+2.4%	$1.08	Q3 2022
30 Jun 2022	1.6%	+0.09%	$7,955,000	4,679,491	+250,000	+5.6%	$1.70	Q2 2022
31 Mar 2022	2%	+1%	$9,125,000	4,429,491	+2,267,178	+105%	$2.06	Q1 2022
31 Dec 2021	2.2%	0%	$8,109,000	2,162,313	0		$3.75	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.